Home
GSK commences phase III study of Benlysta and rituximab...
GSK today announced the start of a phase III study investigating Benlysta (belimumab) in combination with rituximab in adult patients with systemic lupus erythematosus (SLE)....
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.